Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted delivery of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted cancer therapy
Jing Huang, Zhuo Yao, Bowen Li, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 270-279
Closed Access | Times Cited: 25

Showing 25 citing articles:

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 18
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Shipeng He, Yuxin Fang, Yaojin Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 17
Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Mengyang Chang, Feng Gao, Giri Gnawali, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7301-7311
Open Access | Times Cited: 8
Aggregation-induced emission photosensitizer microneedles for enhanced melanoma photodynamic therapy
Ling Liang, Tuokai Peng, Xin Yao Geng, et al.
Biomaterials Science (2024) Vol. 12, Iss. 5, pp. 1263-1273
Closed Access | Times Cited: 5
MOF-based nanoparticles for tumor-targeted protein degradation and photodynamic therapy induce enhanced anti-tumor immunity
Huanhuan Zhu, Fei Gao, Yuan Li, et al.
Nano Today (2024) Vol. 56, pp. 102308-102308
Closed Access | Times Cited: 5
Bioorthogonal Strategy-Triggered In situ Co-Activation of Aggregation-Induced Emission Photosensitizers and Chemotherapeutic Prodrugs for Boosting Synergistic Chemo-Photodynamic-Immunotherapy
Yu Teng, Dianyu Wang, Wenlong Yang, et al.
Biomaterials (2025) Vol. 317, pp. 123092-123092
Closed Access
Unveiling the photophysical mechanistic mysteries of tetrazine-functionalized fluorogenic labels
Tianruo Shen, Xiaogang Liu
Chemical Science (2025)
Open Access
Nanoengineered Microneedles: A Versatile Targeted Delivery System for Theragnostic Applications
Mansi Singh, Rahul Shukla
IntechOpen eBooks (2025)
Closed Access
Targeted Degradation of Bromodomain-Containing Protein 4 Enabled by Reactive Oxygen Species–Activatable NanoPROTACs as an Efficient Strategy to Reverse Liver Fibrosis in Chronic Liver Injury
Tao Bi, Pan Liang, Qixin Zhao, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Preparation and characterization of ASDs improves the solubility and dissolution performance of a PROTAC drug
Heng Zhang, Hengqian Wu, Lili Wang, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106837-106837
Closed Access
Microneedle system for tissue engineering and regenerative medicines: a smart and efficient therapeutic approach
Muhammad Umar Aslam Khan, Muhammad Azhar Aslam, Mohd Faizal Abdullah, et al.
Biofabrication (2024) Vol. 16, Iss. 4, pp. 042005-042005
Closed Access | Times Cited: 3
Controlled bioorthogonal activation of Bromodomain-containing protein 4 degrader by co-delivery of PROTAC and Pd-catalyst for tumor-specific therapy
Zhiyao Li, Tai‐Bai Jiang, Yuan Xu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 441-453
Closed Access | Times Cited: 2
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Mengyao Wu, Yilan Zhao, Chi Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28502-28530
Closed Access | Times Cited: 1
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Leveraging Nanoengineered Microneedle‐Augmented Drug Delivery in Oncological Intervention
Mansi Singh, Rahul Shukla
Particle & Particle Systems Characterization (2024)
Closed Access | Times Cited: 1
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
Yiyang Li, Yike Wu, Shugeng Gao, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 116-144
Closed Access | Times Cited: 1
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Bromodomain and Extra-Terminal Domain Protein 2in Multiple Human Diseases
Yikang Ji, Wantao Chen, Xu Wang
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 3, pp. 277-288
Open Access
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Chuan Feng, et al.
Angewandte Chemie (2024)
Closed Access
Triazines, tetrazines, and fused ring polyaza systems
Pierre Audebert, Vincent Sol
Progress in heterocyclic chemistry (2024), pp. 395-420
Closed Access
Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy
Xiaoling Guan, Xiaowei Xu, Yiwen Tao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie (2024)
Closed Access
Targeted Protein Degraders- The Druggability Perspective
Satinder Singh, Pratima Srivastava
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 3, pp. 539-554
Closed Access
Page 1

Scroll to top